MX9200948A - Composicion farmaceutica para el tratamiento de isquemia cerebral en mamiferos. - Google Patents

Composicion farmaceutica para el tratamiento de isquemia cerebral en mamiferos.

Info

Publication number
MX9200948A
MX9200948A MX9200948A MX9200948A MX9200948A MX 9200948 A MX9200948 A MX 9200948A MX 9200948 A MX9200948 A MX 9200948A MX 9200948 A MX9200948 A MX 9200948A MX 9200948 A MX9200948 A MX 9200948A
Authority
MX
Mexico
Prior art keywords
mammals
treatment
pharmaceutical composition
brain ischemia
ischemia
Prior art date
Application number
MX9200948A
Other languages
English (en)
Inventor
Giuseppe Giardina
Geoffrey Douglas Clarke
Original Assignee
Lo Zambeletti S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lo Zambeletti S P A filed Critical Lo Zambeletti S P A
Publication of MX9200948A publication Critical patent/MX9200948A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX9200948A 1991-03-05 1992-03-04 Composicion farmaceutica para el tratamiento de isquemia cerebral en mamiferos. MX9200948A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919104656A GB9104656D0 (en) 1991-03-05 1991-03-05 Pharmaceuticals

Publications (1)

Publication Number Publication Date
MX9200948A true MX9200948A (es) 1992-11-01

Family

ID=10691041

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9200948A MX9200948A (es) 1991-03-05 1992-03-04 Composicion farmaceutica para el tratamiento de isquemia cerebral en mamiferos.

Country Status (8)

Country Link
EP (1) EP0574477A1 (es)
CA (1) CA2105589A1 (es)
GB (1) GB9104656D0 (es)
IE (1) IE920679A1 (es)
MX (1) MX9200948A (es)
PT (1) PT100188A (es)
WO (1) WO1992015304A2 (es)
ZA (1) ZA921575B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8926560D0 (en) * 1989-11-24 1990-01-17 Zambeletti Spa L Pharmaceuticals
EP0594611A1 (en) * 1990-04-28 1994-05-04 Dr. Lo. Zambeletti S.p.A. Novel 1-(2h-1-oxo-3,4-dihydronaphtyl-6)-acetyl-piperidines, process for their preparation and therapeutic use
CA2558568A1 (en) 2004-03-12 2005-09-29 Eli Lilly And Company Opioid receptor antagonists
US7601844B2 (en) 2006-01-27 2009-10-13 Bristol-Myers Squibb Company Piperidinyl derivatives as modulators of chemokine receptor activity
US7615556B2 (en) 2006-01-27 2009-11-10 Bristol-Myers Squibb Company Piperazinyl derivatives as modulators of chemokine receptor activity
TWI433838B (zh) 2008-06-25 2014-04-11 必治妥美雅史谷比公司 作為趨化因子受體活性調節劑之六氫吡啶衍生物
CA2812526A1 (en) 2010-05-06 2011-11-10 Vertex Pharmaceuticals Incorporated Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
US8642622B2 (en) 2010-06-16 2014-02-04 Bristol-Myers Squibb Company Piperidinyl compound as a modulator of chemokine receptor activity
BR112013019211A2 (pt) 2011-02-02 2021-07-06 Vertex Pharma amidas de piperidina espirocíclicas de pirrolopirazina como moduladores de canais de íon
CN103443105A (zh) 2011-02-18 2013-12-11 沃泰克斯药物股份有限公司 作为离子通道调节剂的苯并二氢吡喃-螺环哌啶酰胺
US8828996B2 (en) 2011-03-14 2014-09-09 Vertex Pharmaceuticals Incorporated Morpholine-spirocyclic piperidine amides as modulators of ion channels

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0330467A1 (en) * 1988-02-23 1989-08-30 Glaxo Group Limited Heterocyclic compounds
GB8804104D0 (en) * 1988-02-23 1988-03-23 Glaxo Group Ltd Chemical compounds
JPH01308229A (ja) * 1988-02-23 1989-12-12 Glaxo Group Ltd 複素環誘導体
GB8813714D0 (en) * 1988-06-09 1988-07-13 Glaxo Group Ltd Chemical compounds
EP0361791B1 (en) * 1988-09-26 1995-11-08 Smithkline Beecham Farmaceutici S.p.A. Azacyclic derivatives useful as medicaments

Also Published As

Publication number Publication date
WO1992015304A3 (en) 1993-06-24
EP0574477A1 (en) 1993-12-22
PT100188A (pt) 1993-05-31
CA2105589A1 (en) 1992-09-06
IE920679A1 (en) 1992-09-09
ZA921575B (en) 1992-12-30
GB9104656D0 (en) 1991-04-17
WO1992015304A2 (en) 1992-09-17

Similar Documents

Publication Publication Date Title
MX9207008A (es) Medicamentos para el tratamiento de condiciones inflamatorias o para la analgesia.
MX9205637A (es) Metodo para prevenir el rechazo de aloinjertos.
MX9202507A (es) Composicion farmaceutica para el tratamiento de esofagitis de reflujo.
MX164619B (es) Composicion para el tratamiento de lesiones cutaneas
MX9201258A (es) Compuestos para el tratamiento del cancer y procedimiento para su preparacion.
MX9200429A (es) Procedimiento para el acortamiento del tiempo de acceso
BR9507732A (pt) Composição farmacêutica para o tratamento de glaucoma
IT8720034A0 (it) Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali.
MX9203208A (es) Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos.
GB2195532B (en) Therapeutic agent for the treatment of disorders associated with cerebral ischemia
MX9202034A (es) Composicion de derivados de antibioticos de macrolida para el tratamiento o prevencion de mastitis en rumiantes.
IT8322949A0 (it) Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello.
MX9204485A (es) Composicion farmaceutica para el tratamiento de enfermedades inflamatorias.
BR9405887A (pt) Medicamento para o tratamento de infecções por retrovirus
MX9200555A (es) Composicion farmaceutica para la aplicacion topicaterapeutica en el tratamiento de catarata pre-senil y senil.
ES1019136Y (es) Cesta perfeccionada para el juego de cesta-punta.
MX9201665A (es) Composicion farmaceutica para el tratamiento de infecciones del virus de inmunodeficiencia humana del tipo 1 en mamiferos.
MX9203089A (es) Composicion para el tratamiento de esquisofrenia.
MX9201735A (es) Composicion farmaceutica para el tratamiento y profilaxis de inflamacion y dolor en mamiferos.
MX9203587A (es) Composicion farmaceutica para el tratamiento de la osteodistro fia renal.
ES1017890Y (es) Dispositivo para el tratamiento de uneros.
ES1020134Y (es) Mesa audiovisual para el juego de bingo.
ES1015773Y (es) Rail para el montaje de muebles desplazables.
ES1003998Y (es) Dispositivo perfeccionado para el ensamble lateral de paneles.
ES1002501Y (es) Hucha perfeccionada para el ahorro aumentativo por niveles